Humacyte, Inc. ( HUMAW) - Stock Earnings
Stock symbol HUMAW is outdated, potentially delisted? Maybe it is available on other exchange?
HUMAW Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 6, 2026, midnight | — / — | — | — / — | — |
HUMAW Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -24.8 million USD | 467000 USD |
| 2026Q1 | -17.6 million USD | 495000 USD |
| 2026Q2 | -36.8 million USD | 406000 USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
HUMAW Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -110.8 million USD | — USD |
| 2024 | -148.7 million USD | — USD |
| 2025 | -40.8 million USD | 2.0 million USD |
| 2026 Est. | — | — |
HUMAW
Price: $0
52 week price:
Earnings Per Share: -3.16 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 31189
Market Capitalization: 1.1 million